CymaBay Therapeutics Inc. (CBAY) by event type
CBAY moves most on analyst downgrades — a median of +0.16% at 30 minutes across 24 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the CBAY overview →
How CBAY reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 872 of 2,603 | 24 | +0.16% | 67% | 0.00% |
| Rating reiterations 580 of 3,522 | 19 | +0.16% | 58% | 0.00% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how CBAY usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Rating reiterations → · CBAY overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | 167 | -0.32% | 42% |
| Boundless Bio, Inc. (BOLD) | 166 | -0.48% | 44% |
| Innoviva, Inc. (INVA) | 166 | +0.10% | 54% |
| MediWound Ltd. - Ordinary Shares (MDWD) | 166 | +0.11% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.